Why Massachusetts?
Massachusetts plays a central role in AstraZeneca’s mission to shape the future of medicine.
With a growing presence across Kendall Square, Seaport and 100 Binney, we are bringing together cutting-edge science, world-class talent, academic partnerships and advanced technologies to accelerate breakthrough medicines for patients around the world.
- 75+ year Massachusetts legacy
- $2B Massachusetts investment
- 2,000+ colleagues across Greater Boston
- Academic and ecosystem partnerships
- Sustainable campus design
- Future growth plans across the region
One ecosystem. Multiple ways to make an impact.
Kendall Square Strategic R&D Center
Where AI, automation, biologics, cell therapy and advanced modalities come together to accelerate the next generation of medicines.
100 Binney Street
Advancing next-generation rare disease therapeutics across gene therapy, gene editing and targeted biologics.
Seaport
Home to Alexion’s Global Headquarters, connecting scientific, strategic and commercial leadership to the global rare disease mission.
Greater Boston-led innovation
Moving science further
Our teams bring together scientific expertise, advanced technologies and leading academic collaborations to help accelerate transformative medicines for patients worldwide.
Built for the future
From AI-enabled discovery to advanced therapeutics, Massachusetts is where diverse teams collaborate to help push the boundaries of what science can do.
Sustainable from the start
Our newest facilities were designed to help science and people thrive, creating environments that support wellbeing, collaboration and sustainability
Join our team in Kendall Square
Work where bold science meets global possibility.
In Kendall Square, world-class scientists, technologists and innovators come together to help shape the future of medicine.
From Oncology and BioPharmaceuticals R&D, Cell Therapy to AI and advanced modalities, you'll work alongside diverse minds transforming bold ideas into meaningful impact for patients around the world.
Explore opportunities across:
- Oncology
- BioPharmaceuticals R&D
- AI & Enterprise Technology
- Advanced Modalities
- Cell Therapy
- Biologics
Join the diverse minds helping push the boundaries of what science can do.
Apply Now
- Associate Director (m/f/d), Computational Pathology Biomarker Lead (Oncology/BioPharma) R-257540 Munich, Germany
- Director, Site Management & Monitoring Cell Therapy (m/w/d) R-259738 Hamburg, Germany
- Medical Representative - CVRM - HCM R-260244 Ho Chi Minh City, Vietnam
- Account Specialist – R&I – Hanoi R-260243 Đống Đa, Vietnam
- Account Specialist – R&I – HCM R-260242 Ho Chi Minh City, Vietnam
- Senior Business Analyst, Finance Controlling (6-month Contract) R-260240 Petaling Jaya, Malaysia
- Analyst - Data Scientist R-258871 Bengaluru, India
- Project Lead / Financial Controller – Group Finance Reporting R-259391 Stockholm, Sweden
- Agentic AI Scientist R-250533 Gaithersburg, Maryland
- Senior Maintenance Technician R-257656 Santa Monica, California
Cell therapy is a unique modality – by engineering living cells to precisely target disease we have the potential to transform patient outcomes across multiple therapeutic areas. At AstraZeneca, we are pioneering cell therapy at scale, investing in state-of-the-art platforms, building global capabilities and pushing the boundaries of science. Our aim is to ensure many more patients can benefit from cell therapy worldwide.
Craig Maxwell-
